Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade

Medicine & Life Sciences

• AEE 788 100%
• Mouth Neoplasms 56%
• Receptor Protein-Tyrosine Kinases 54%
• Cell- and Tissue-Based Therapy 48%
• Endothelial Cells 37%
• Paclitaxel 23%
• Neoplasms 16%
• Head and Neck Neoplasms 14%
• Apoptosis 11%
• Growth 9%
• Epidermal Growth Factor 9%
• Nude Mice 8%
• Protein-Tyrosine Kinases 8%
• Vascular Endothelial Growth Factor A 8%
• Phosphorylation 6%
• Cell Proliferation 6%
• Vascular Endothelial Growth Factor Receptor-2 5%
• Squamous Cell Carcinoma of Head and Neck 5%
• Microvessels 4%
• Mitogen-Activated Protein Kinases 4%
• Tongue 4%
• Phosphotransferases 3%
• Placebos 3%
• Clinical Trials 3%
• Staining and Labeling 3%
• Cell Line 2%
• Survival 2%